KR20130066630A - 자가면역 질환의 치료 - Google Patents

자가면역 질환의 치료 Download PDF

Info

Publication number
KR20130066630A
KR20130066630A KR1020127031868A KR20127031868A KR20130066630A KR 20130066630 A KR20130066630 A KR 20130066630A KR 1020127031868 A KR1020127031868 A KR 1020127031868A KR 20127031868 A KR20127031868 A KR 20127031868A KR 20130066630 A KR20130066630 A KR 20130066630A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
alkoxy
halogen
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020127031868A
Other languages
English (en)
Korean (ko)
Inventor
피터 게르겔리
에릭 발스트로엠
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42199281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20130066630(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20130066630A publication Critical patent/KR20130066630A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/28Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/30Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020127031868A 2010-05-06 2011-05-05 자가면역 질환의 치료 Withdrawn KR20130066630A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10162079 2010-05-06
EP10162079.7 2010-05-06
PCT/EP2011/057203 WO2011138393A1 (en) 2010-05-06 2011-05-05 Treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
KR20130066630A true KR20130066630A (ko) 2013-06-20

Family

ID=42199281

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127031868A Withdrawn KR20130066630A (ko) 2010-05-06 2011-05-05 자가면역 질환의 치료

Country Status (24)

Country Link
US (1) US20130172297A1 (https=)
EP (1) EP2566470A1 (https=)
JP (1) JP2013530937A (https=)
KR (1) KR20130066630A (https=)
CN (1) CN102869353A (https=)
AU (1) AU2011249784B2 (https=)
BR (1) BR112012028190A2 (https=)
CA (1) CA2795394A1 (https=)
CL (1) CL2012003091A1 (https=)
CR (1) CR20120566A (https=)
CU (1) CU20120154A7 (https=)
EA (1) EA201201514A1 (https=)
EC (1) ECSP12012312A (https=)
IL (1) IL222690A0 (https=)
MA (1) MA34285B1 (https=)
MX (1) MX2012012926A (https=)
NZ (1) NZ603999A (https=)
PE (1) PE20130612A1 (https=)
PH (1) PH12012502418A1 (https=)
SG (1) SG185746A1 (https=)
TN (1) TN2012000509A1 (https=)
TW (1) TW201201814A (https=)
WO (1) WO2011138393A1 (https=)
ZA (1) ZA201207710B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519539B (zh) * 2010-12-21 2016-02-01 Kyorin Seiyaku Kk Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1431275B1 (en) * 2001-09-27 2010-04-07 Kyorin Pharmaceutical Co., Ltd. Diaryl ether derivative, addition salt thereof, and immunosuppressant
MXPA04002679A (es) * 2001-09-27 2004-07-30 Kyorin Seiyaku Kk Derivados de sulfuro de diarilo, sales de los mismos y agentes inmunosupresores que utilizan los mismos.
KR101003877B1 (ko) 2002-09-19 2010-12-30 교린 세이야꾸 가부시키 가이샤 아미노알코올 유도체와 그 부가염 및 면역 억제제
US7456157B2 (en) 2003-02-18 2008-11-25 Kyorin Pharmaceutical Co., Ltd. Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
JP4716996B2 (ja) * 2003-05-26 2011-07-06 武田薬品工業株式会社 スルホピロール
CN1874996B (zh) 2003-08-28 2011-05-18 诺瓦提斯公司 氨基丙醇衍生物
EP1723138B1 (en) * 2004-02-11 2010-07-14 Basilea Pharmaceutica AG Substituted benzimidazoles and their use for inducing apoptosis
WO2006041015A1 (ja) * 2004-10-12 2006-04-20 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体とその付加塩及び免疫抑制剤
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds
SI2295049T1 (sl) * 2005-09-09 2015-03-31 Novartis Ag Zdravljenje avtoimunskih bolezni

Also Published As

Publication number Publication date
CU20120154A7 (es) 2013-03-27
CR20120566A (es) 2013-01-09
PH12012502418A1 (en) 2018-03-21
SG185746A1 (en) 2013-01-30
BR112012028190A2 (pt) 2016-08-02
IL222690A0 (en) 2012-12-31
MX2012012926A (es) 2012-12-17
ECSP12012312A (es) 2012-12-28
CA2795394A1 (en) 2011-11-10
NZ603999A (en) 2014-06-27
PE20130612A1 (es) 2013-06-06
TN2012000509A1 (en) 2014-04-01
US20130172297A1 (en) 2013-07-04
EA201201514A1 (ru) 2013-05-30
CN102869353A (zh) 2013-01-09
MA34285B1 (fr) 2013-06-01
AU2011249784B2 (en) 2014-03-06
WO2011138393A1 (en) 2011-11-10
AU2011249784A1 (en) 2012-12-20
JP2013530937A (ja) 2013-08-01
ZA201207710B (en) 2013-06-26
CL2012003091A1 (es) 2013-03-22
TW201201814A (en) 2012-01-16
EP2566470A1 (en) 2013-03-13

Similar Documents

Publication Publication Date Title
US8008286B2 (en) Method for treatment of neuropathic pain
EP3795566B1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
KR20110018897A (ko) 수용성 아세트아미노펜 유사체
CN105061376A (zh) 色甘酸衍生物以及成像和治疗的相关方法
AU2014340182A1 (en) Cromolyn derivatives and related methods of imaging and treatment
US20230002337A1 (en) Cystine diamide analogs for the prevention of cystine stone formation in cystinuria
KR20130066630A (ko) 자가면역 질환의 치료
CN111635430A (zh) 一种非甾体化合物、其制备方法和用途
EP4284352A1 (en) Enhanced anti-proliferative and antitumor immune effects of mitochondria-targeted hydroxyurea
CN111320662A (zh) 一类n-苄基取代的二脒那秦衍生物及其药物用途
US20240174608A1 (en) Compounds for brain imaging
JP7819298B2 (ja) Ep4拮抗剤化合物及びその塩、結晶多形並びに使用
US9745275B2 (en) Pain-related compound and medical composition
BR112021013637A2 (pt) Inibidores da síntese de leucotrieno
US20250129083A1 (en) Imidazotetrazine compounds and treatment of tmz-resistant cancers
JP2019142815A (ja) 心不全改善剤
EP3858357A1 (en) Use of azole compounds to stimulate the immune system and as inhibitors for s-pla2gib
CN117597122A (zh) 拟甲状腺素药的脂肪酸酰胺水解酶(faah)可裂解前药以及与外周限制性faah抑制剂的组合
JP2025533120A (ja) イミダゾリジニルバニリン酸エーテル誘導体の線維化を伴う疾患の治療における使用
RU2421219C1 (ru) Ингибиторы протеинкиназы с
WO2022119864A1 (en) Compounds for the treatment of sars
US20150087682A1 (en) Method for Treating Scleroderma
HK1165214B (en) Bicyclic aryl sphingosine 1-phosphate analogs
CN102659617A (zh) L-酪氨酸类衍生物及其药物组合物与应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121205

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid